1. Programas de optimización de uso de antimicrobianos (PROA) en hospitales españoles: documento de consenso GEIH-SEIMC, SEFH y SEMPSPH
    Enferm Infecc Microbiol Clin. 2012;30:22.e1-e23
  2. Therapeutic monitoring of vancomycin in adult patients:
    Infectious Diseases Society of America. Amer J Health-System Pharmacy, Vol. 66, Issue 1, 82-98
  3. Developing an Institutional Program to Enhance Antimicrobial Stewardship
    Clin Infect Dis. (2007) 44 (2): 159-177.
  4. Vancomycin Therapeutic Guidelines
    Infectious Diseases Society of America. Clinical Infectious Diseases 2009;49:325–327
  5. Fatal and Severe Liver Injuries Associated With Rifampin and Pyrazinamide for Latent Tuberculosis Infection, and Revisions in American Thoracic Society/CDC Recommendations.
    Recomendaciones de American Thoracic Society y CDC con el apoyo de la Infectious Diseases Society of America. Agosto de 2001.
  6. Updated Guidelines for the Use of Rifabutin or Rifampin for the Treatment and Prevention of Tuberculosis Among HIV-Infected Patients Taking Protease Inhibitors or Nonnucleoside Reverse Transcriptase Inhibitors.
    Centers for Disease Control and Prevention (CDC) – Federal Government Agency [U.S.]MMWR Morb Mortal Wkly Rep 2000 Mar 10;49(09);185-9.
  7. Introduction to Antifungal Drugs.
    Infectious Diseases Society of America. Clinical Infectious Diseases 2000;30:653-657.